sort news by category

Insight, Strategy, Impact,

apprenticeships, awards, B2G, Biden, Bills, Blueprint, bolt on, Boris, Boris Johnson, Brexit, business, careers, climate change, climate crisis, clinical trials, commissioning, Communications, Consumer, consumer demands, COP, covid, COVID 19, Crisis comms, culture, d, David Laws, defence, Deregulation, Devolution, Digital, Disruption, diversity, Due Diligence, economic policy, Education, elections, Energy, Energy and Environment, engagement, Environment, Equality, ESG, EU, europe, exit plan, Financial Services, general election, General News, gig economy, GK culture, gk report, Government, government affairs, Health, health & Care Bill, health and care, health and social care, health funding, health insights, Healthcare, Hendy, housing, HS2, i have a voice, infrastructure, insight, insight report, insights, integrated review, internship, Investment, Investor, Investor Backed Businesses, Investor Services, investors, Ioan, Jack Sansum, Jeremy Corbyn, job, labour conference, Labour market, Legislation, legistation, levy, life sciences, local government, lockdown, medical devices, Medicines, membership bodies, mental health, mental health services, nationalisation, NHS, no, No deal, parliament, pharma, pharmaceuticals, Planning, policy, Political Due Diligence, Politics, Pride Month, Prime Minister, Private Equity, Privatisation, Public Affairs, Public Relations, Public spending, Queen's Speech, rail, recruitment, REF, regulation, sales, Scotland, Scott, Select Committee, select committees, skills, Social Care, Spending Review, Strategic Communications, students, sustainability, Tax, Technology, The Conservative Party, The Labour Party, trade bodies, transformation, Transport, uk, UK Politics, university, US, US election, Wales, Waste, Winter Plan, women, Workplace,

What does a Biden presidency mean for Private Equity?

By Ioan Phillips, Senior Political Analyst Joe Biden has finally been confirmed as US President, following several fraught days of ballot-counting. But what does his victory mean for Private Equity? Many in the industry will be glad to see the back of the volatility that characterised policy-making in the Trump administration. While the platform Biden ran on suggests higher taxation and tighter regulation overall (trends that are typically negative for deal activity),...

Assessing bolt-on risks and opportunities in a time of huge political and economic uncertainty

It’s an uncomfortable truth, but the impact of COVID means that many companies now seem attractive and viable investment opportunities. Many of the investors we speak to expect to see more appealing valuations and more assets becoming available, as owner managers and...

How is the policy and regulatory environment for rail changing?

With the resolution – for now – of the ongoing debate over the High Speed 2 rail line, as well as debates over public ownership of passenger services, what should businesses with an interest in the rail sector be bearing in mind from a policy and regulatory perspective?

Weak pound and economic uncertainty: an opportunity for US investors?

With uncertainty over Brexit continuing to hit investor confidence and the “Pound on a rollercoaster” in the currency markets, there has been a noticeable slowdown in deal volume in the domestic M&A market whilst people wait for a resolution...

logo
GK Strategy 23rd Oct, 2019 Insight
Brexit , Investment , investors , UK Politics
2 min read

Private Equity investment in Pharma – why is the UK bucking the global trend?

In recent years we’ve become used to claims that the impasse of Brexit is drying up investment in UK life sciences. The argument also goes that global investment by pharmaceuticals in R&D – predicted to grow to $181 billion by 2022 – will instead flow to other countries. There is evidence that can support this theory but if you scrape below the surface and look at investment by private equity into life sciences the picture looks quite different. The figures actually suggest that...

logo
GK Strategy 25th Sep, 2019 Insight
Brexit , Healthcare , Investment , pharma
5 min read

What investors should watch out for in big tech regulation

We have known for a while that the relatively lenient regulatory environment for big tech companies is coming to an end. While western governments have encouraged growth of these companies through a soft approach to taxation and user rights, they are now making moves to crack down on the skewed distribution of power between tech giants, their competitors and users. The issue is now overlaid by ongoing US-EU trade tensions as a result of US President Donald Trump’s threat of sanctions on...

How to take advantage of the rise in B Corps

Four years since the launch of B Corps in the UK and many of the UK’s for-profit organisations are yet to join this global movement, which commits B Corp certified companies meet the highest standards of verified social and environmental performance, public transparency, and legal accountability to balance profit and purpose. What is a B Corp? To date there are 2, 788 B Corps across 150 industries in over 60 countries, including 199 here in the UK. The community of B Corp holders...

logo
GK Strategy 24th Jul, 2019 Insight
business , ESG , Investment
3 min read

The case for ESG due diligence

ESG: moving beyond due diligence as a red flag exercise Higher asset prices and more competitive bidding has driven an increase in the breadth and depth of due diligence, including ESG. ESG due diligence on B2C assets has increased as consumers and retailers have become more concerned about ESG issues, such as consumer protection, waste and recycling, and ethical sourcing. ESG due diligence on B2B assets has also increased as clients focus more on responsible...